Economic evaluation of type 2 diabetes prevention programmes: Markov model of low- and high-intensity lifestyle programmes and metformin in participants with different categories of intermediate hyperglycaemia

Background National guidance on preventing type 2 diabetes mellitus (T2DM) in the UK recommends low-intensity lifestyle interventions for individuals with intermediate categories of hyperglycaemia defined in terms of impaired fasting glucose (IFG) or ‘at-risk’ levels of HbA1c. In a recent systematic...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	BMC medicine Ročník 16; číslo 1; s. 16 - 12
Hlavní autoři:	Roberts, Samantha, Craig, Dawn, Adler, Amanda, McPherson, Klim, Greenhalgh, Trisha
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	London BioMed Central 30.01.2018 BioMed Central Ltd BMC
Témata:	Analysis Biomedicine Care and treatment Cost-Benefit Analysis Diabetes Mellitus, Type 2 - economics Diabetes Mellitus, Type 2 - prevention & control Diabetes prevention Dosage and administration Economic aspects Economic evaluation Female Health aspects Health care costs Humans Hyperglycemia Hyperglycemia - drug therapy Impaired fasting glucose Impaired glucose tolerance Intermediate hyperglycaemia Lifestyles Male management and treatment Markov processes Medicine Medicine & Public Health Metformin Metformin - economics Metformin - therapeutic use Prediabetes Prevention Research Article Risk factors Type 2 diabetes United Kingdom Impaired fasting glucose Economic evaluation HbA1c in at-risk range Prediabetes Intermediate hyperglycaemia Diabetes prevention Impaired glucose tolerance Cost-effective
ISSN:	1741-7015, 1741-7015
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!